Basic Information
RNALocate ID: | RLID-D:11000271 |
RNA Symbol: | hsa-miR-18a-5p |
Localization: | Microvesicle |
RNA Information
RNA Name: | hsa-miR-18a-5p |
RNA ID: | miRBase:MIMAT0000072 |
RNA Category: | miRNA |
Species: | Homo sapiens |
Localization Information
Tissue/Cell Line: | Colon cancer cell line (LIM1863)|Fibroblasts|Mesenchymal stem cells |
Database: | EVmiRNA |
Other Subcellular Localization
RNALocate ID | Localization | Tissue/Cell line | PubMed ID |
RLID:11000707 | Exosome | Breast milk | 22211110 |
RLID:11000708 | Exosome | Brain tissue | 23382797 |
RLID:11000709 | Exosome | Plasma | 23663360 |
RLID-D:11001156 | Exosome | Breast milk|Cell lines|Epididymal epithelial cells|Osteoblast|Plasma|Primary glioblastoma neurosphere cells|Primary keratinocyte|Saliva|Serum|Urine |
ncRNA Disease Information
Resource | RNA Symbol | Disease | Link |
MNDR | hsa-miR-18a-5p | Splenic marginal zone lymphoma | MNDR-E-MI-21718 |
MNDR | hsa-miR-18a-5p | Multiple sclerosis chronic progressive | MNDR-E-MI-21719 |
MNDR | hsa-miR-18a-5p | Oral squamous cell carcinoma | MNDR-E-MI-21720 |
MNDR | hsa-miR-18a-5p | Large cell neuroendocrine cancer | MNDR-E-MI-21721 |
MNDR | hsa-miR-18a-5p | Follicular cleaved lymphoma | MNDR-E-MI-21722 |
MNDR | hsa-miR-18a-5p | Medulloblastoma | MNDR-E-MI-21723 |
MNDR | hsa-miR-18a-5p | Small intestinal neuroendocrine tumor | MNDR-E-MI-21724 |
MNDR | hsa-miR-18a-5p | High-grade serous ovarian carcinoma | MNDR-E-MI-21725 |
MNDR | hsa-miR-18a-5p | Ovarian clear cell carcinoma | MNDR-E-MI-21726 |
MNDR | hsa-miR-18a-5p | Uterine corpus endometrial carcinoma | MNDR-E-MI-21727 |
MNDR | hsa-miR-18a-5p | Autism spectrum disorder | MNDR-E-MI-21728 |
MNDR | hsa-miR-18a-5p | Lymphoma | MNDR-E-MI-21729 |
MNDR | hsa-miR-18a-5p | Lymphoma non-hodgkin | MNDR-E-MI-21730 |
MNDR | hsa-miR-18a-5p | Estrogen-receptor positive breast cancer | MNDR-E-MI-21731 |
MNDR | hsa-miR-18a-5p | Estrogen-receptor negative breast cancer | MNDR-E-MI-21732 |
MNDR | hsa-miR-18a-5p | Progesterone-receptor positive breast cancer | MNDR-E-MI-21733 |
MNDR | hsa-miR-18a-5p | Progesterone-receptor negative breast cancer | MNDR-E-MI-21734 |
MNDR | hsa-miR-18a-5p | Her2-receptor positive breast cancer | MNDR-E-MI-21735 |
MNDR | hsa-miR-18a-5p | Triple negative breast cancer | MNDR-E-MI-21736 |
MNDR | hsa-miR-18a-5p | Breast cancer luminal | MNDR-E-MI-21737 |
MNDR | hsa-miR-18a-5p | Thyroid carcinoma anaplastic | MNDR-E-MI-21738 |
MNDR | hsa-miR-18a-5p | Small intestine cancer | MNDR-E-MI-21739 |
MNDR | hsa-miR-18a-5p | Dermatomyositis | MNDR-E-MI-21740 |
MNDR | hsa-miR-18a-5p | Prostate cancer | MNDR-E-MI-21741 |
MNDR | hsa-miR-18a-5p | Gastric cancer | MNDR-E-MI-21742 |
MNDR | hsa-miR-18a-5p | Gastric lymphoma | MNDR-E-MI-21743 |
MNDR | hsa-miR-18a-5p | Alzheimer disease | MNDR-E-MI-21744 |
MNDR | hsa-miR-18a-5p | Intracranial aneurysm | MNDR-E-MI-21745 |
MNDR | hsa-miR-18a-5p | Bladder cancer | MNDR-E-MI-21746 |
MNDR | hsa-miR-18a-5p | Esophageal carcinoma | MNDR-E-MI-21747 |
MNDR | hsa-miR-18a-5p | Sarcoma | MNDR-E-MI-21748 |
MNDR | hsa-miR-18a-5p | Dysautonomia familial | MNDR-E-MI-21749 |
MNDR | hsa-miR-18a-5p | Head and neck cancer | MNDR-E-MI-21750 |
MNDR | hsa-miR-18a-5p | Leukemia | MNDR-E-MI-21751 |
MNDR | hsa-miR-18a-5p | Cardiovascular disease | MNDR-E-MI-21752 |
MNDR | hsa-miR-18a-5p | Carotid stenosis | MNDR-E-MI-21753 |
MNDR | hsa-miR-18a-5p | Lung cancer | MNDR-E-MI-21754 |
MNDR | hsa-miR-18a-5p | Parkinson disease | MNDR-E-MI-21755 |
MNDR | hsa-miR-18a-5p | Machado-joseph disease | MNDR-E-MI-21756 |
MNDR | hsa-miR-18a-5p | Basal-like breast cancer | MNDR-E-MI-21757 |
MNDR | hsa-miR-18a-5p | Thyroid cancer | MNDR-E-MI-21758 |
MNDR | hsa-miR-18a-5p | Pituitary neoplasms | MNDR-E-MI-21759 |
MNDR | hsa-miR-18a-5p | Pancreatic cancer | MNDR-E-MI-21760 |
MNDR | hsa-miR-18a-5p | Melanoma | MNDR-E-MI-21761 |
MNDR | hsa-miR-18a-5p | Rectum adenocarcinoma | MNDR-E-MI-21762 |
MNDR | hsa-miR-18a-5p | Nephroblastoma | MNDR-E-MI-21763 |
MNDR | hsa-miR-18a-5p | Colon cancer | MNDR-E-MI-21764 |
MNDR | hsa-miR-18a-5p | Colon adenocarcinoma | MNDR-E-MI-21765 |
MNDR | hsa-miR-18a-5p | Multiple sclerosis relapsing-remitting | MNDR-E-MI-21766 |
MNDR | hsa-miR-18a-5p | Familial ovarian cancer | MNDR-E-MI-21767 |
MNDR | hsa-miR-18a-5p | Prostate adenocarcinoma | MNDR-E-MI-21768 |
MNDR | hsa-miR-18a-5p | Kidney cancer | MNDR-E-MI-21769 |
MNDR | hsa-miR-18a-5p | Carcinoma ductal breast | MNDR-E-MI-21770 |
MNDR | hsa-miR-18a-5p | Glioblastoma | MNDR-E-MI-21771 |
MNDR | hsa-miR-18a-5p | Astrocytoma | MNDR-E-MI-21772 |
MNDR | hsa-miR-18a-5p | Glioma | MNDR-E-MI-21773 |
MNDR | hsa-miR-18a-5p | Amyotrophic lateral sclerosis | MNDR-E-MI-21774 |
MNDR | hsa-miR-18a-5p | Osteosarcoma | MNDR-E-MI-21775 |
MNDR | hsa-miR-18a-5p | Liposarcoma | MNDR-E-MI-21776 |
MNDR | hsa-miR-18a-5p | Coronary artery disease | MNDR-E-MI-21777 |
MNDR | hsa-miR-18a-5p | Pancreatic ductal adenocarcinoma | MNDR-E-MI-21778 |
MNDR | hsa-miR-18a-5p | Infarction middle cerebral artery | MNDR-E-MI-21779 |
MNDR | hsa-miR-18a-5p | Meningioma | MNDR-E-MI-21780 |
MNDR | hsa-miR-18a-5p | Uterine cancer | MNDR-E-MI-21781 |
MNDR | hsa-miR-18a-5p | Cervical adenocarcinoma | MNDR-E-MI-21782 |
MNDR | hsa-miR-18a-5p | Gastric adenocarcinoma | MNDR-E-MI-21783 |
MNDR | hsa-miR-18a-5p | Cervical squamous cell carcinoma | MNDR-E-MI-21784 |
MNDR | hsa-miR-18a-5p | Pituitary adenoma | MNDR-E-MI-21785 |
MNDR | hsa-miR-18a-5p | Lung squamous cell carcinoma | MNDR-E-MI-21786 |
MNDR | hsa-miR-18a-5p | Non-small cell lung adenocarcinoma | MNDR-E-MI-21787 |
MNDR | hsa-miR-18a-5p | Lung adenocarcinoma | MNDR-E-MI-21788 |
MNDR | hsa-miR-18a-5p | Thyroid carcinoma | MNDR-E-MI-21789 |
MNDR | hsa-miR-18a-5p | Ovarian carcinoma | MNDR-E-MI-21790 |
MNDR | hsa-miR-18a-5p | Bladder urothelial carcinoma | MNDR-E-MI-21791 |
MNDR | hsa-miR-18a-5p | Pancreatic adenocarcinoma | MNDR-E-MI-21792 |
MNDR | hsa-miR-18a-5p | Carcinoma renal cell | MNDR-E-MI-21793 |
MNDR | hsa-miR-18a-5p | Kidney renal papillary cell carcinoma | MNDR-E-MI-21794 |
MNDR | hsa-miR-18a-5p | Clear cell renal cell carcinoma | MNDR-E-MI-21795 |
MNDR | hsa-miR-18a-5p | Esophageal cancer | MNDR-E-MI-21796 |
MNDR | hsa-miR-18a-5p | Lung small cell carcinoma | MNDR-E-MI-21797 |
MNDR | hsa-miR-18a-5p | Head and neck squamous cell carcinoma | MNDR-E-MI-21798 |
MNDR | hsa-miR-18a-5p | T acute lymphoblastic leukemia | MNDR-E-MI-21799 |
MNDR | hsa-miR-18a-5p | Acute t cell leukemia | MNDR-E-MI-21800 |
MNDR | hsa-miR-18a-5p | Acute heart failure | MNDR-E-MI-21801 |
MNDR | hsa-miR-18a-5p | Breast invasive carcinoma | MNDR-E-MI-21802 |
MNDR | hsa-miR-18a-5p | Hepatocellular carcinoma | MNDR-E-MI-21803 |
MNDR | hsa-miR-18a-5p | Familiar ovarian carcinoma | MNDR-E-MI-21804 |
MNDR | hsa-miR-18a-5p | B-cell lymphoma | MNDR-E-MI-21805 |
MNDR | hsa-miR-18a-5p | Rheumatoid arthritis | MNDR-E-MI-21806 |
MNDR | hsa-miR-18a-5p | T-cell leukemia | MNDR-E-MI-21807 |
MNDR | hsa-miR-18a-5p | Retinoblastoma | MNDR-E-MI-21808 |
MNDR | hsa-miR-18a-5p | Neuroblastoma | MNDR-E-MI-21809 |
MNDR | hsa-miR-18a-5p | Hodgkin lymphoma | MNDR-E-MI-21810 |
MNDR | hsa-miR-18a-5p | Burkitt lymphoma | MNDR-E-MI-21811 |
MNDR | hsa-miR-18a-5p | Tonsil cancer | MNDR-E-MI-21812 |
MNDR | hsa-miR-18a-5p | Acute myelogenous leukemia | MNDR-E-MI-21813 |
MNDR | hsa-miR-18a-5p | Colorectal cancer | MNDR-E-MI-21814 |
MNDR | hsa-miR-18a-5p | Nasopharyngeal carcinoma | MNDR-E-MI-21815 |
MNDR | hsa-miR-18a-5p | Multiple myeloma | MNDR-E-MI-21816 |
MNDR | hsa-miR-18a-5p | Ependymoma | MNDR-E-MI-21817 |
MNDR | hsa-miR-18a-5p | Nasopharyngeal cancer | MNDR-E-MI-21818 |
MNDR | hsa-miR-18a-5p | Pseudorabies | MNDR-E-MI-21819 |
MNDR | hsa-miR-18a-5p | Epstein-barr virus infections | MNDR-E-MI-21820 |
MNDR | hsa-miR-18a-5p | Stroke lacunar | MNDR-E-MI-21821 |
MNDR | hsa-miR-18a-5p | Breast cancer her3+ negative | MNDR-E-MI-21822 |
MNDR | hsa-miR-18a-5p | Duke A | MNDR-E-MI-21823 |
RNA Interaction Information
Resource | RNA Symbol | Species | Link | RNALocate ID |
RNAInter | ATM | Homo sapiens | RR00158089 |
TOP